Persistence of SARS-CoV-2 neutralizing antibodies and anti-Omicron IgG induced by BNT162b2 mRNA vaccine in patients with autoimmune inflammatory rheumatic disease: an explanatory study in JapanResearch in context

• Váldodahkkit: Yuta Yamaguchi (Dahkki), Shinichiro Nameki (Dahkki), Yasuhiro Kato (Dahkki), Ryotaro Saita (Dahkki), Tomoharu Sato (Dahkki), Sayaka Nagao (Dahkki), Teruaki Murakami (Dahkki), Yuko Yoshimine (Dahkki), Saori Amiya (Dahkki), Takayoshi Morita (Dahkki), Yasutaka Okita (Dahkki), Takahiro Kawasaki (Dahkki), Jun Fujimoto (Dahkki), Yasutaka Ueda (Dahkki), Yuichi Maeda (Dahkki), Akane Watanabe (Dahkki), Hyota Takamatsu (Dahkki), Sumiyuki Nishida (Dahkki), Yoshihito Shima (Dahkki), Masashi Narazaki (Dahkki), Atsushi Kumanogoh (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Elsevier, 2023-03-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Summary: Background: Autoimmune inflammatory rheumatic disease (AIRD) patients are at high risk of the coronavirus disease 2019 (COVID-19), but the medium-term effects of immunosuppressants on vaccine efficacy are unknown. We investigated the duration of humoral responses against severe acute respir...